Literature DB >> 3281113

Reversibility of cortical hyperostosis following long-term prostaglandin E1 therapy in infants with ductus-dependent congenital heart disease.

A Høst1, S Halken, P E Andersen.   

Abstract

Two neonates with complex cyanotic congenital heart disease, receiving long-term prostaglandin E1 infusion, for 59 and 78 days respectively, demonstrated significant radiographic changes of symmetric cortical hyperostosis of the long bones. Bone biopsies from one of the patients elucidated the histological changes and serial X-rays revealed regression of the hyperostosis. Long-term follow-up after 13 months did not reveal any late bony changes or growth disturbance.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3281113     DOI: 10.1007/bf02387559

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  12 in total

1.  Prostaglandin-induced periostitis: a complication of long-term PGE1 infusion in an infant with congenital heart disease.

Authors:  R E Ringel; J I Brenner; P J Haney; J E Burns; A L Moulton; M A Berman
Journal:  Radiology       Date:  1982-03       Impact factor: 11.105

2.  Cortical hyperostosis following long-term administration of prostaglandin E1 in infants with cyanotic congenital heart disease.

Authors:  K Ueda; A Saito; H Nakano; M Aoshima; M Yokota; R Muraoka; T Iwaya
Journal:  J Pediatr       Date:  1980-11       Impact factor: 4.406

3.  Long-term low-dose prostaglandin E1 administration.

Authors:  P Pitlick; J W French; A Maze; K J Kimble; R L Ariagno; B A Reitz
Journal:  J Pediatr       Date:  1980-02       Impact factor: 4.406

4.  Long-term low-dose prostaglandin E1 administration.

Authors:  K Sone; M Tashiro; T Fujinaga; T Tomomasa; K Tokuyama; T Kuroume
Journal:  J Pediatr       Date:  1980-11       Impact factor: 4.406

5.  Widening of cranial sutures after long-term prostaglandin E2 therapy in two newborn infants.

Authors:  H Hoevels-Guerich; L Haferkorn; M Persigehl; R Hofstetter; G von Bernuth
Journal:  J Pediatr       Date:  1984-07       Impact factor: 4.406

6.  E-type prostaglandins: a new emergency therapy for certain cyanotic congenital heart malformations.

Authors:  P M Olley; F Coceani; E Bodach
Journal:  Circulation       Date:  1976-04       Impact factor: 29.690

7.  Effects of exogenous prostanoids on the proliferation of osteoblast-like cells in vitro.

Authors:  J H Feyen; A Di Bon; A van der Plas; C W Löwik; P J Nijweide
Journal:  Prostaglandins       Date:  1985-11

8.  Evaluation of oral and low dose intravenous prostaglandin E2 in management of ductus dependent congenital heart disease.

Authors:  E D Silove; D G Roberts; J V de Giovanni
Journal:  Arch Dis Child       Date:  1985-11       Impact factor: 3.791

9.  Medical manipulation of the ductus arteriosus.

Authors:  R B Elliott; M B Starling; J M Neutze
Journal:  Lancet       Date:  1975-01-18       Impact factor: 79.321

10.  Palliation of cyanotic congenital heart disease in infancy with E-type prostaglandins.

Authors:  J M Neutze; M B Starling; R B Elliott; B G Barratt-Boyes
Journal:  Circulation       Date:  1977-02       Impact factor: 29.690

View more
  3 in total

1.  Poul Erik Andersen's radiological work on Osteochondrodysplasias and interventional radiology.

Authors:  Poul Erik Andersen
Journal:  World J Radiol       Date:  2011-08-28

2.  Radiologic features of gastric outlet obstruction in infants after long-term prostaglandin administration.

Authors:  P Babyn; N Peled; D Manson; O Dagan; M M Silver; G Koren
Journal:  Pediatr Radiol       Date:  1995

Review 3.  Prostaglandin E1 for maintaining ductal patency in neonates with ductal-dependent cardiac lesions.

Authors:  Smita Akkinapally; Shilpa G Hundalani; Madhulika Kulkarni; Caraciolo J Fernandes; Antonio G Cabrera; Binoy Shivanna; Mohan Pammi
Journal:  Cochrane Database Syst Rev       Date:  2018-02-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.